logo
Boeing posts smaller loss as jet deliveries rise

Boeing posts smaller loss as jet deliveries rise

Reuters29-07-2025
July 29 (Reuters) - Boeing (BA.N), opens new tab reported a smaller second-quarter loss on Tuesday as the U.S. planemaker ramped up jet production and deliveries, recovering from a regulatory crisis and a major strike that halted most production last year.
Shares of the company rose 1.5% in premarket trading.
After years of grappling with quality issues and production delays on its flagship 737 MAX, Boeing has cautiously ramped up monthly output this year. In May, the company produced 38 737s. Production has been stable since then, according to the company.
"As we continue to execute our Safety & Quality Plan, there's more stability in our operations," CEO Kelly Ortberg said in a letter to Boeing employees on Tuesday.
The U.S. Federal Aviation Administration had capped the production of Boeing's best selling 737 MAX jets following a mid-air panel blowout in a nearly new jet in January 2024.
"We plan to seek FAA approval to increase to rate 42 when our key performance indicators (KPIs) show that we're ready," Ortberg added.
It has delivered 206 737 MAX jets through the first half of the year. Wall Street closely tracks aircraft deliveries, because planemakers collect much of their payment when they hand over jets to customers.
Boeing also increased 787 production at its plant in Charleston, South Carolina, from five aircraft a month to seven a month.
Through the first half of the year, the planemaker has booked 668 orders, or 625 net orders after cancellations and conversions.
An improvement in deliveries marks a pivotal step in Boeing's effort to rebound from years of production disruptions and crises that piled on debt, highlighting the urgency of accelerating output to restore financial stability.
The planemaker posted a net loss of $612 million, or 92 cents per share, for the quarter through June, compared with $1.44 billion, or $2.33 per share, a year earlier.
However, the planemaker continues to face pressure from supply chain disruptions that have delayed production and limited its ability to meet surging aerospace demand. It posted a loss of nearly $12 billion in 2024 due to challenges across its major business units including charges on its defense programs.
It also remains exposed to U.S. President Donald Trump's sweeping tariffs, which could increase parts costs and further strain an already fragile supply chain.
Boeing's revenue for the quarter through June rose 35% to $22.75 billion.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US drillers cut oil and gas rigs for third week in a row, Baker Hughes says
US drillers cut oil and gas rigs for third week in a row, Baker Hughes says

Reuters

time31 minutes ago

  • Reuters

US drillers cut oil and gas rigs for third week in a row, Baker Hughes says

Aug 8 (Reuters) - U.S. energy firms this week cut the number of oil and natural gas rigs operating for a third week in a row, energy services firm Baker Hughes (BKR.O), opens new tab said in its closely followed report on Friday. The oil and gas rig count, an early indicator of future output, fell by one to 539 in the week to August 8. , , Baker Hughes said oil rigs rose by one to 411 this week, while gas rigs fell by one to 123, and miscellaneous rigs fell by one to five. The oil and gas rig count declined by about 5% in 2024 and 20% in 2023 as lower U.S. oil and gas prices over the past couple of years prompted energy firms to focus more on boosting shareholder returns and paying down debt rather than increasing output. The independent exploration and production (E&P) companies tracked by U.S. financial services firm TD Cowen said they planned to cut capital expenditures by around 4% in 2025 from levels seen in 2024. That compares with roughly flat year-over-year spending in 2024, increases of 27% in 2023, 40% in 2022, and 4% in 2021. Even though analysts forecast U.S. spot crude prices would decline for a third year in a row in 2025, the U.S. Energy Information Administration (EIA) projected crude output would rise from a record 13.2 million barrels per day (bpd) in 2024 to around 13.4 million bpd in 2025. On the gas side, the EIA projected a 68% increase in spot gas prices in 2025 would prompt producers to boost drilling activity this year after a 14% price drop in 2024 caused several energy firms to cut output for the first time since the COVID-19 pandemic reduced demand for the fuel in 2020. The EIA projected gas output would rise to 105.9 billion cubic feet per day (bcfd) in 2025, up from 103.2 bcfd in 2024 and a record 103.6 bcfd in 2023.

Medtech Heartflow valued at $2.27 billion in solid Nasdaq debut
Medtech Heartflow valued at $2.27 billion in solid Nasdaq debut

Reuters

time31 minutes ago

  • Reuters

Medtech Heartflow valued at $2.27 billion in solid Nasdaq debut

Aug 8 (Reuters) - Heartflow (HTFL.O), opens new tab shares surged 47.4% in their Nasdaq debut on Friday, giving the medtech firm a valuation of $2.27 billion, as the IPO market gathers momentum and outrides tariff worries. The stock opened at $28, compared with the IPO price of $19, signaling robust investor appetite for revenue-positive companies leveraging artificial intelligence for healthcare. Heartflow sold about 16.67 million shares in its IPO on Thursday and raised $316.7 million. Its raised marketed price was $17 to $18 per share. The Bain Capital-backed company's solid market debut comes as expectations of a softer trade policy and lower interest rates boost investor sentiment, which had nosedived after U.S. tariffs in April stoked recession fears. Space tech startup Firefly Aerospace (FLY.O), opens new tab and design software firm Figma (FIG.N), opens new tab saw stellar first-day reactions in recent days, strengthening prospects for tech-focused companies to go public. Heartflow's first-day pop could help boost market perception for future medtech IPOs. Beta Bionics (BBNX.O), opens new tab and Kestra Medical (KMTS.O), opens new tab had solid debuts earlier this year, but are now trading below their IPO price, like most medtech IPOs of the past year.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store